CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

$277.38 -0.92 (-0.33%)

High $278.08	Low $276.68	Trades 24,705	Turnover $270,464,856	Volume 970,129
30 June 2023 at 4:22pm

Market Cap (22-Jul) $58,130,333,696 (6th)	Close (30-Jun) $277.38 0 (0%)	Volume (30-Jun) 970,129	Shortsold (16-Jul) 4,543,649 (0.95%) (244th)
52w High $269.15	52w Low $90.00	P/E 13.09	EPS 8.95
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 1+

Short Interest

ASIC data, 16 Jul 2026

% Shorted

0.95% 0.05

vs 1.00% prior report

Most Shorted Rank

244th

of 718 shorted ASX stocks

Peak Short

3.33%

Jun 2010

Days to Cover

2.5

at 50d avg vol

View full short position history →

	Subject
	CSL Ann: Market Update
	1 (current) 2 3
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Shareholder Briefing
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Becoming a substantial holder
	CSL Ann: Ceasing to be a substantial holder
	CSL Ann: CSL European Investor Site Tour Presentations
	CSL Ann: Update - Dividend/Distribution - CSL
	CSL Ann: Application for quotation of securities - CSL
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Final Director's Interest Notice
	CSL Ann: Application for quotation of securities - CSL
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Change of Director's Interest Notice x 8
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Portfolio Update
	CSL Ann: Dividend/Distribution - CSL
	CSL Ann: CSL Half Year Results Announcement & Investor Presentation
	CSL Ann: CSL Statutory Accounts for the Half Year Ended 31 Dec 2022
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: New Segment Note Historical Financial Detail
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notice of Investor/Analyst Briefing 2023 Half Year Result
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Initial Director's Interest Notice
	CSL Ann: Appointment of CSLs next CEO & Managing Director
	CSL Ann: Becoming a substantial holder
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: CSL Highlights Progress Across Strong R&D Pipeline
	CSL Ann: Licence Agreement - Next Generation mRNA Vaccine Technology
	CSL Ann: CSL Notice of Research & Development Investor Briefing
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: CSL Vifor Market Briefing
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: CSL 2022 AGM Results
	CSL Ann: CSL 2022 AGM Chair and CEO Speech and Presentation
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Application for quotation of securities - CSL
	CSL Ann: Update - Dividend/Distribution - CSL
	CSL Ann: Notification regarding unquoted securities - CSL
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Change of Director's Interest Notice
	CSL Ann: Notification of cessation of securities - CSL
	CSL Ann: Notification regarding unquoted securities - CSL

Similar Companies

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
22-Jul	$117.94	1,089,414	-3.44 (2.83%)
21-Jul	$121.38	863,550	-1.23 (1.00%)
20-Jul	$122.61	670,829	-0.71 (0.58%)
17-Jul	$123.32	1,619,085	-75.02 (37.82%)
18-Sep	$198.34	2,097,346	-9.48 (4.56%)
12-Sep	$207.82	1,061,162	+2.01 (0.98%)
11-Sep	$205.81	1,481,808	-3.44 (1.64%)
05-Sep	$209.25	1,145,142	-1.60 (0.76%)
04-Sep	$210.85	1,184,425	+4.23 (2.05%)
03-Sep	$206.62	1,235,226	-6.27 (2.95%)
29-Aug	$212.89	1,120,057	+0.19 (0.09%)
28-Aug	$212.70	788,032	-3.90 (1.80%)
22-Aug	$216.60	2,451,697	-9.40 (4.16%)
21-Aug	$226.00	2,278,663	-44.37 (16.41%)
15-Aug	$270.37	600,591	+0.27 (0.10%)
4 up, 11 down, and 0 flat days

CSL Health Care Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma